홈 > 시장보고서 > 의료기기 > 바이오장비

시장보고서

상품코드

1786773

세계의 ATP 분석 시장 - 규모, 점유율, 동향, 산업 분석 보고서 : 유형별, 용도별, 최종 용도별, 지역별 시장 예측(2025-2034년)

ATP Assays Market Size, Share, Trends, Industry Analysis Report By Type, By Application, By End Use, By Region - Market Forecast, 2025-2034

발행일: 2025년 07월 | 리서치사:

Polaris Market Research | 페이지 정보: 영문 129 Pages | 배송안내 : 1-2일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

Polaris Market Research의 최신 조사에 따르면 세계의 ATP 분석 시장 규모는 2034년까지 72억 3,000만 달러에 이를 전망입니다. 이 조사 보고서는 현재 시장 역학을 자세히 파악하고 향후 시장 성장에 대한 분석을 제공합니다.

ATP(Adenosine Triphosphate) 분석은 생물학적 시료에서 ATP 농도를 측정하는 데 사용되는 생화학적 검사로 세포 대사, 생존력 및 에너지 상태에 대한 통찰력을 제공합니다. 세포 프로세스의 주요 에너지 캐리어인 ATP는 창약 정보학, 미생물학, 환경 모니터링, 암 연구에 필수적입니다.

ATP 분석의 원리는 ATP가 빛으로 변하는 효소적 변환에 의존하며, 일반적으로 반딧불이로부터 유래된 효소인 루시퍼라제를 사용합니다. ATP의 존재하에, 루시퍼라제는 루시페린의 산화를 촉매하고 ATP 농도에 비례하는 생물 발광을 방출합니다. 이 반응은 민감하고 펨토몰 수준의 ATP에서도 감지할 수 있습니다.

ATP 분석은 세포 생존율과 세포 독성 연구에 널리 사용됩니다. 의약품 개발은 처리 된 세포의 ATP 고갈을 측정하여 세포 사멸과 대사 억제를 나타내며 화합물의 독성 효과를 스크리닝하는 데 도움이 됩니다. 마찬가지로, 암 연구에서도 ATP 검정은 종양 세포 중의 ATP 수준을 모니터링하여 화학요법제의 효능을 평가합니다. 미생물의 생존 능력 검사에서도 살아있는 미생물이 측정 가능한 ATP를 포함하기 때문에 물, 식품, 의약품의 오염을 검출하기 위해 ATP 분석이 사용되고 있습니다.

ATP 분석 시장 보고서 하이라이트

유형별로는 발광 ATP 분석 부문이 제약, 생명공학 및 식음료 산업에서 널리 채택되었기 때문에 2024년 매출 점유율에서 33.12%를 차지했습니다.

용도별로는 세포 생존율, 세포독성, 화합물의 효능을 평가하기 위한 신속하고 신뢰성 높은 수법에 대한 수요 증가에 의해 창약 분야가 2024년의 수익 점유율의 34.17%를 차지했습니다.

최종 용도별로는 제약 및 바이오테크놀러지 기업이 2024년 매출 점유율의 40.23%를 차지했습니다. 이는 약물 스크리닝, 독성 시험 및 치료 효과의 평가에서 세포 에너지 측정에 대한 의존도가 증가하고 있기 때문입니다.

북미는 2024년 세계 ATP 분석 시장 수익의 38.15%를 차지했습니다. 이 이점은 지역의 강력한 생명 공학 및 제약 산업이 약물 개발, 독성 테스트 및 세포 생존력 연구를 위해 ATP 검출에 의존하고 있기 때문입니다.

유럽 시장은 ATP 기반 위생 모니터링을 의무화하는 엄격한 규제 프레임워크로 인해 2034년에 상당한 시장 점유율을 차지할 것으로 예측됩니다.

아시아태평양의 산업은 특히 중국, 인도, 일본에서의 제약 및 바이오테크놀러지 산업의 확대에 의해 향후 수년간 가장 빠른 페이스로 성장할 것으로 예측되고 있습니다.

ATP 분석 시장의 세계 주요 기업으로는 Abcam plc, Becton, Dickinson and Company(BD), Biomerieux SA, Biotium, Danaher Corporation, Lonza Group Ltd., Merck KGaA, PerkinElmer Inc., Promega Corporation, Quest Diagnostics Incorporated, Reaction Biology, Thermo Fisher Scientific 등이 있습니다.

시장 현황
ATP 분석 시장 역학
- 성장 촉진요인과 기회
  - 의약품 및 바이오테크놀러지 조사에서 응용 확대
  - 만성질환의 부담 증대
- 억제요인과 과제
  - 미생물 유래 ATP와 비미생물 유래 ATP의 특이성 결여
PESTLE 분석
ATP 분석 시장의 최종 용도의 동향
밸류체인 분석

제5장 세계의 ATP 분석 시장 : 유형별

주요 조사 결과
소개
발광 ATP 분석
효소 ATP 분석
생물 발광 공명 에너지 이동(BRET) ATP 분석
세포 기반 ATP 분석
기타

제6장 세계의 ATP 분석 시장 : 용도별

주요 조사 결과
소개
신약개발 및 의약품 개발
임상 진단
환경시험
식품의 안전성과 품질 시험
기타

제7장 세계의 ATP 분석 시장 : 최종 용도별

주요 조사 결과
소개
제약 및 바이오테크놀러지 기업
학술기관 및 연구기관
병원 및 진단실험실

제8장 세계의 ATP 분석 시장 : 지역별

주요 조사 결과
소개
- ATP 분석 시장 평가 : 지역별, 2020-2034년
북미
- 북미 : 유형별, 2020-2034년
- 북미 : 용도별, 2020-2034년
- 북미 : 최종 용도별, 2020-2034년1
- 미국
- 캐나다
유럽
- 유럽 : 유형별, 2020-2034년
- 유럽 : 용도별, 2020-2034년
- 유럽 : 최종 용도별, 2020-2034년
- 영국
- 프랑스
- 독일
- 이탈리아
- 스페인
- 네덜란드
- 러시아
- 기타 유럽
아시아태평양
- 아시아태평양 : 유형별, 2020-2034년
- 아시아태평양 : 용도별, 2020-2034년
- 아시아태평양 : 최종 용도별, 2020-2034년
- 중국
- 인도
- 말레이시아
- 일본
- 인도네시아
- 한국
- 호주
- 기타 아시아태평양
중동 및 아프리카
- 중동 및 아프리카 : 유형별, 2020-2034년
- 중동 및 아프리카 : 용도별, 2020-2034년
- 중동 및 아프리카 : 최종 용도별, 2020-2034년
- 사우디아라비아
- 아랍에미리트(UAE)
- 이스라엘
- 남아프리카
- 기타 중동 및 아프리카
라틴아메리카
- 라틴아메리카 : 유형별, 2020-2034년
- 라틴아메리카 : 용도별, 2020-2034년
- 라틴아메리카 : 최종 용도별, 2020-2034년
- 멕시코
- 브라질
- 아르헨티나
- 기타 라틴아메리카

제9장 경쟁 구도

확대 및 인수 분석
- 확대
- 인수
제휴/협업/합의/공개

제10장 기업 프로파일

Abcam plc
Becton, Dickinson and Company(BD)
Biomerieux SA
Biotium
Danaher Corporation
Lonza Group Ltd.
Merck KGaA
PerkinElmer Inc.
Promega Corporation
Quest Diagnostics Incorporated
Reaction Biology
Thermo Fisher Scientific

JHS 25.08.14

The ATP assays market size is expected to reach USD 7.23 billion by 2034, according to a new study by Polaris Market Research. The report "ATP Assays Market Share, Size, Trends, Industry Analysis Report By Type [Luminometric ATP Assays, Enzymatic ATP Assays, Bioluminescence Resonance Energy Transfer (BRET) ATP Assays, Cell-based ATP Assays, Others], By Application, By End Use, By Region; Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

ATP (adenosine triphosphate) assays are biochemical tests used to measure the concentration of ATP in biological samples, providing insights into cellular metabolism, viability, and energy status. ATP, the primary energy carrier for cellular processes, is essential in drug discovery informatics, microbiology, environmental monitoring, and cancer research.

The principle behind ATP assays relies on the enzymatic conversion of ATP to light, typically using luciferase, an enzyme derived from fireflies. In the presence of ATP, luciferase catalyzes the oxidation of luciferin, emitting bioluminescence that is proportional to the ATP concentration. This reaction is highly sensitive, allowing detection of even femtomole levels of ATP.

ATP assays are widely used in cell viability and cytotoxicity studies. In drug development, they help screen compounds for toxic effects by measuring ATP depletion in treated cells, indicating cell death or metabolic inhibition. Similarly, in cancer research, ATP assays evaluate the efficacy of chemotherapeutic agents by monitoring ATP levels in tumor cells. Microbial viability testing also employs ATP assays to detect contamination in water, food, and pharmaceuticals, as living microorganisms contain measurable ATP.

ATP Assays Market Report Highlights

In terms of type, the luminometric ATP assays segment held 33.12% of revenue share in 2024 due to its widespread adoption across pharmaceutical, biotechnology, and food and beverage industries.

Based on application, the drug discovery segment accounted for 34.17% of the revenue share in 2024, driven by the increasing demand for rapid and reliable methods to evaluate cell viability, cytotoxicity, and compound efficacy.

In terms of end use, the pharmaceutical and biotechnology companies segment dominated the revenue share in 2024 by holding 40.23% of the share. This is attributed to the increasing reliance on cellular energy measurements during drug screening, toxicity testing, and evaluations of therapeutic efficacy.

North America accounted for a 38.15% share of the global ATP assays market revenue in 2024. This dominance is attributed to the region's strong biotechnology and pharmaceutical industries, which rely on ATP detection for drug development, toxicity testing, and cell viability studies.

The market in Europe is projected to hold a substantial market share in 2034 due to strict regulatory frameworks that mandate ATP-based hygiene monitoring.

The industry in Asia Pacific is projected to grow at the fastest pace in the coming years, owing to expanding pharmaceutical and biotechnology industries, particularly in China, India, and Japan.

A few global key players in the ATP assays market include Abcam plc; Becton, Dickinson and Company (BD); Biomerieux SA; Biotium; Danaher Corporation; Lonza Group Ltd.; Merck KGaA; PerkinElmer Inc.; Promega Corporation; Quest Diagnostics Incorporated; Reaction Biology; and Thermo Fisher Scientific.

Polaris Market Research has segmented the ATP assays market report on the basis of type, application, end use, and region:

By Type Outlook (Revenue, USD Billion, 2020-2034)

Luminometric ATP Assays

Enzymatic ATP Assays

Bioluminescence Resonance Energy Transfer (BRET) ATP Assays

Cell-based ATP Assays

Others

By Application Mode Outlook (Revenue, USD Billion, 2020-2034)

Drug Discovery and Development

Clinical Diagnostics

Environmental Testing

Food Safety and Quality Testing

Others

By End Use Outlook (Revenue, USD Billion, 2020-2034)

Pharmaceutical and Biotechnology Companies

Academic and Research Institutes

Hospital and Diagnostics Laboratories

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America

U.S.

Canada

Europe

Germany

France

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Source
- 3.2.1. Primary Source
- 3.2.2. Secondary Source

4. Global ATP Assays Market Insights

4.1. ATP Assays Market - Market Snapshot
4.2. ATP Assays Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Expanding application in Pharmaceutical and Biotechnology Research
  - 4.2.1.2. Rising Burden of Chronic Diseases
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. Lack of specificity for microbial vs. non-microbial ATP
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. ATP Assays Market End Use Trends
4.6. Value Chain Analysis

5. Global ATP Assays Market, by Type

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global ATP Assays Market, by Type, 2020-2034 (USD Billion)
5.3. Luminometric ATP Assays
- 5.3.1. Global ATP Assays Market, by Luminometric ATP Assays, by Region, 2020-2034 (USD Billion)
5.4. Enzymatic ATP Assays
- 5.4.1. Global ATP Assays Market, by Enzymatic ATP Assays, by Region, 2020-2034 (USD Billion)
5.5. Bioluminescence Resonance Energy Transfer (BRET) ATP Assays
- 5.5.1. Global ATP Assays Market, by Bioluminescence Resonance Energy Transfer (BRET) ATP Assays, by Region, 2020-2034 (USD Billion)
5.6. Cell-based ATP Assays
- 5.6.1. Global ATP Assays Market, by Cell-based ATP Assays, by Region, 2020-2034 (USD Billion)
5.7. Others
- 5.7.1. Global ATP Assays Market, by Others, by Region, 2020-2034 (USD Billion)

6. Global ATP Assays Market, by Application

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global ATP Assays Market, by Application, 2020-2034 (USD Billion)
6.3. Drug Discovery and Development
- 6.3.1. Global ATP Assays Market, by Drug Discovery and Development, by Region, 2020-2034 (USD Billion)
6.4. Clinical Diagnostics
- 6.4.1. Global ATP Assays Market, by Clinical Diagnostics, by Region, 2020-2034 (USD Billion)
6.5. Environmental Testing
- 6.5.1. Global ATP Assays Market, by Environmental Testing, by Region, 2020-2034 (USD Billion)
6.6. Food Safety and Quality Testing
- 6.6.1. Global ATP Assays Market, by Food Safety and Quality Testing, by Region, 2020-2034 (USD Billion)
6.7. Others
- 6.7.1. Global ATP Assays Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global ATP Assays Market, by End Use

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global ATP Assays Market, by End Use, 2020-2034 (USD Billion)
7.3. Pharmaceutical and Biotechnology Companies
- 7.3.1. Global ATP Assays Market, by Pharmaceutical and Biotechnology Companies, by Region, 2020-2034 (USD Billion)
7.4. Academic and Research Institutes
- 7.4.1. Global ATP Assays Market, by Academic and Research Institutes, by Region, 2020-2034 (USD Billion)
7.5. Hospital and Diagnostics Laboratories
- 7.5.1. Global ATP Assays Market, by Hospital and Diagnostics Laboratories, by Region, 2020-2034 (USD Billion)

8. Global ATP Assays Market, by Geography

8.1. Key Findings
8.2. Introduction
- 8.2.1. ATP Assays Market Assessment, By Geography, 2020-2034 (USD Billion)
8.3. ATP Assays Market - North America
- 8.3.1. North America: ATP Assays Market, by Type, 2020-2034 (USD Billion)
- 8.3.2. North America: ATP Assays Market, by Application, 2020-2034 (USD Billion)
- 8.3.3. North America: ATP Assays Market, by End Use, 2020-2034 (USD Billion)
- 8.3.4. ATP Assays Market - U.S.
  - 8.3.4.1. U.S.: ATP Assays Market, by Type, 2020-2034 (USD Billion)
  - 8.3.4.2. U.S.: ATP Assays Market, by Application, 2020-2034 (USD Billion)
  - 8.3.4.3. U.S.: ATP Assays Market, by End Use, 2020-2034 (USD Billion)
- 8.3.5. ATP Assays Market - Canada
  - 8.3.5.1. Canada: ATP Assays Market, by Type, 2020-2034 (USD Billion)
  - 8.3.5.2. Canada: ATP Assays Market, by Application, 2020-2034 (USD Billion)
  - 8.3.5.3. Canada: ATP Assays Market, by End Use, 2020-2034 (USD Billion)
8.4. ATP Assays Market - Europe
- 8.4.1. Europe: ATP Assays Market, by Type, 2020-2034 (USD Billion)
- 8.4.2. Europe: ATP Assays Market, by Application, 2020-2034 (USD Billion)
- 8.4.3. Europe: ATP Assays Market, by End Use, 2020-2034 (USD Billion)
- 8.4.4. ATP Assays Market - UK
  - 8.4.4.1. UK: ATP Assays Market, by Type, 2020-2034 (USD Billion)
  - 8.4.4.2. UK: ATP Assays Market, by Application, 2020-2034 (USD Billion)
  - 8.4.4.3. UK: ATP Assays Market, by End Use, 2020-2034 (USD Billion)
- 8.4.5. ATP Assays Market - France
  - 8.4.5.1. France: ATP Assays Market, by Type, 2020-2034 (USD Billion)
  - 8.4.5.2. France: ATP Assays Market, by Application, 2020-2034 (USD Billion)
  - 8.4.5.3. France: ATP Assays Market, by End Use, 2020-2034 (USD Billion)
- 8.4.6. ATP Assays Market - Germany
  - 8.4.6.1. Germany: ATP Assays Market, by Type, 2020-2034 (USD Billion)
  - 8.4.6.2. Germany: ATP Assays Market, by Application, 2020-2034 (USD Billion)
  - 8.4.6.3. Germany: ATP Assays Market, by End Use, 2020-2034 (USD Billion)
- 8.4.7. ATP Assays Market - Italy
  - 8.4.7.1. Italy: ATP Assays Market, by Type, 2020-2034 (USD Billion)
  - 8.4.7.2. Italy: ATP Assays Market, by Application, 2020-2034 (USD Billion)
  - 8.4.7.3. Italy: ATP Assays Market, by End Use, 2020-2034 (USD Billion)
- 8.4.8. ATP Assays Market - Spain
  - 8.4.8.1. Spain: ATP Assays Market, by Type, 2020-2034 (USD Billion)
  - 8.4.8.2. Spain: ATP Assays Market, by Application, 2020-2034 (USD Billion)
  - 8.4.8.3. Spain: ATP Assays Market, by End Use, 2020-2034 (USD Billion)
- 8.4.9. ATP Assays Market - Netherlands
  - 8.4.9.1. Netherlands: ATP Assays Market, by Type, 2020-2034 (USD Billion)
  - 8.4.9.2. Netherlands: ATP Assays Market, by Application, 2020-2034 (USD Billion)
  - 8.4.9.3. Netherlands: ATP Assays Market, by End Use, 2020-2034 (USD Billion)
- 8.4.10. ATP Assays Market - Russia
  - 8.4.10.1. Russia: ATP Assays Market, by Type, 2020-2034 (USD Billion)
  - 8.4.10.2. Russia: ATP Assays Market, by Application, 2020-2034 (USD Billion)
  - 8.4.10.3. Russia: ATP Assays Market, by End Use, 2020-2034 (USD Billion)
- 8.4.11. ATP Assays Market - Rest of Europe
  - 8.4.11.1. Rest of Europe: ATP Assays Market, by Type, 2020-2034 (USD Billion)
  - 8.4.11.2. Rest of Europe: ATP Assays Market, by Application, 2020-2034 (USD Billion)
  - 8.4.11.3. Rest of Europe: ATP Assays Market, by End Use, 2020-2034 (USD Billion)
8.5. ATP Assays Market - Asia Pacific
- 8.5.1. Asia Pacific: ATP Assays Market, by Type, 2020-2034 (USD Billion)
- 8.5.2. Asia Pacific: ATP Assays Market, by Application, 2020-2034 (USD Billion)
- 8.5.3. Asia Pacific: ATP Assays Market, by End Use, 2020-2034 (USD Billion)
- 8.5.4. ATP Assays Market - China
  - 8.5.4.1. China: ATP Assays Market, by Type, 2020-2034 (USD Billion)
  - 8.5.4.2. China: ATP Assays Market, by Application, 2020-2034 (USD Billion)
  - 8.5.4.3. China: ATP Assays Market, by End Use, 2020-2034 (USD Billion)
- 8.5.5. ATP Assays Market - India
  - 8.5.5.1. India: ATP Assays Market, by Type, 2020-2034 (USD Billion)
  - 8.5.5.2. India: ATP Assays Market, by Application, 2020-2034 (USD Billion)
  - 8.5.5.3. India: ATP Assays Market, by End Use, 2020-2034 (USD Billion)
- 8.5.6. ATP Assays Market - Malaysia
  - 8.5.6.1. Malaysia: ATP Assays Market, by Type, 2020-2034 (USD Billion)
  - 8.5.6.2. Malaysia: ATP Assays Market, by Application, 2020-2034 (USD Billion)
  - 8.5.6.3. Malaysia: ATP Assays Market, by End Use, 2020-2034 (USD Billion)
- 8.5.7. ATP Assays Market - Japan
  - 8.5.7.1. Japan: ATP Assays Market, by Type, 2020-2034 (USD Billion)
  - 8.5.7.2. Japan: ATP Assays Market, by Application, 2020-2034 (USD Billion)
  - 8.5.7.3. Japan: ATP Assays Market, by End Use, 2020-2034 (USD Billion)
- 8.5.8. ATP Assays Market - Indonesia
  - 8.5.8.1. Indonesia: ATP Assays Market, by Type, 2020-2034 (USD Billion)
  - 8.5.8.2. Indonesia: ATP Assays Market, by Application, 2020-2034 (USD Billion)
  - 8.5.8.3. Indonesia: ATP Assays Market, by End Use, 2020-2034 (USD Billion)
- 8.5.9. ATP Assays Market - South Korea
  - 8.5.9.1. South Korea: ATP Assays Market, by Type, 2020-2034 (USD Billion)
  - 8.5.9.2. South Korea: ATP Assays Market, by Application, 2020-2034 (USD Billion)
  - 8.5.9.3. South Korea: ATP Assays Market, by End Use, 2020-2034 (USD Billion)
- 8.5.10. ATP Assays Market - Australia
  - 8.5.10.1. Australia: ATP Assays Market, by Type, 2020-2034 (USD Billion)
  - 8.5.10.2. Australia: ATP Assays Market, by Application, 2020-2034 (USD Billion)
  - 8.5.10.3. Australia: ATP Assays Market, by End Use, 2020-2034 (USD Billion)
- 8.5.11. ATP Assays Market - Rest of Asia Pacific
  - 8.5.11.1. Rest of Asia Pacific: ATP Assays Market, by Type, 2020-2034 (USD Billion)
  - 8.5.11.2. Rest of Asia Pacific: ATP Assays Market, by Application, 2020-2034 (USD Billion)
  - 8.5.11.3. Rest of Asia Pacific: ATP Assays Market, by End Use, 2020-2034 (USD Billion)
8.6. ATP Assays Market - Middle East & Africa
- 8.6.1. Middle East & Africa: ATP Assays Market, by Type, 2020-2034 (USD Billion)
- 8.6.2. Middle East & Africa: ATP Assays Market, by Application, 2020-2034 (USD Billion)
- 8.6.3. Middle East & Africa: ATP Assays Market, by End Use, 2020-2034 (USD Billion)
- 8.6.4. ATP Assays Market - Saudi Arabia
  - 8.6.4.1. Saudi Arabia: ATP Assays Market, by Type, 2020-2034 (USD Billion)
  - 8.6.4.2. Saudi Arabia: ATP Assays Market, by Application, 2020-2034 (USD Billion)
  - 8.6.4.3. Saudi Arabia: ATP Assays Market, by End Use, 2020-2034 (USD Billion)
- 8.6.5. ATP Assays Market - UAE
  - 8.6.5.1. UAE: ATP Assays Market, by Type, 2020-2034 (USD Billion)
  - 8.6.5.2. UAE: ATP Assays Market, by Application, 2020-2034 (USD Billion)
  - 8.6.5.3. UAE: ATP Assays Market, by End Use, 2020-2034 (USD Billion)
- 8.6.6. ATP Assays Market - Israel
  - 8.6.6.1. Israel: ATP Assays Market, by Type, 2020-2034 (USD Billion)
  - 8.6.6.2. Israel: ATP Assays Market, by Application, 2020-2034 (USD Billion)
  - 8.6.6.3. Israel: ATP Assays Market, by End Use, 2020-2034 (USD Billion)
- 8.6.7. ATP Assays Market - South Africa
  - 8.6.7.1. South Africa: ATP Assays Market, by Type, 2020-2034 (USD Billion)
  - 8.6.7.2. South Africa: ATP Assays Market, by Application, 2020-2034 (USD Billion)
  - 8.6.7.3. South Africa: ATP Assays Market, by End Use, 2020-2034 (USD Billion)
- 8.6.8. ATP Assays Market - Rest of Middle East & Africa
  - 8.6.8.1. Rest of Middle East & Africa: ATP Assays Market, by Type, 2020-2034 (USD Billion)
  - 8.6.8.2. Rest of Middle East & Africa: ATP Assays Market, by Application, 2020-2034 (USD Billion)
  - 8.6.8.3. Rest of Middle East & Africa: ATP Assays Market, by End Use, 2020-2034 (USD Billion)
8.7. ATP Assays Market - Latin America
- 8.7.1. Latin America: ATP Assays Market, by Type, 2020-2034 (USD Billion)
- 8.7.2. Latin America: ATP Assays Market, by Application, 2020-2034 (USD Billion)
- 8.7.3. Latin America: ATP Assays Market, by End Use, 2020-2034 (USD Billion)
- 8.7.4. ATP Assays Market - Mexico
  - 8.7.4.1. Mexico: ATP Assays Market, by Type, 2020-2034 (USD Billion)
  - 8.7.4.2. Mexico: ATP Assays Market, by Application, 2020-2034 (USD Billion)
  - 8.7.4.3. Mexico: ATP Assays Market, by End Use, 2020-2034 (USD Billion)
- 8.7.5. ATP Assays Market - Brazil
  - 8.7.5.1. Brazil: ATP Assays Market, by Type, 2020-2034 (USD Billion)
  - 8.7.5.2. Brazil: ATP Assays Market, by Application, 2020-2034 (USD Billion)
  - 8.7.5.3. Brazil: ATP Assays Market, by End Use, 2020-2034 (USD Billion)
- 8.7.6. ATP Assays Market - Argentina
  - 8.7.6.1. Argentina: ATP Assays Market, by Type, 2020-2034 (USD Billion)
  - 8.7.6.2. Argentina: ATP Assays Market, by Application, 2020-2034 (USD Billion)
  - 8.7.6.3. Argentina: ATP Assays Market, by End Use, 2020-2034 (USD Billion)
- 8.7.7. ATP Assays Market - Rest of Latin America
  - 8.7.7.1. Rest of Latin America: ATP Assays Market, by Type, 2020-2034 (USD Billion)
  - 8.7.7.2. Rest of Latin America: ATP Assays Market, by Application, 2020-2034 (USD Billion)
  - 8.7.7.3. Rest of Latin America: ATP Assays Market, by End Use, 2020-2034 (USD Billion)

9. Competitive Landscape

9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

10.1. Abcam plc
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
10.2. Becton, Dickinson and Company (BD)
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
10.3. Biomerieux SA
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
10.4. Biotium
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
10.5. Danaher Corporation
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
10.6. Lonza Group Ltd.
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
10.7. Merck KGaA
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
10.8. PerkinElmer Inc.
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
10.9. Promega Corporation
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
10.10. Quest Diagnostics Incorporated
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
10.11. Reaction Biology
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development
10.12. Thermo Fisher Scientific
- 10.12.1. Company Overview
- 10.12.2. Financial Performance
- 10.12.3. Product Benchmarking
- 10.12.4. Recent Development

02-2025-2992
(주말 및 공휴일 제외)

라이선스 / 가격

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 4,250

￦ 5,921,000

PDF (Multi User License)

PDF 보고서를 동일 기업 20명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 5,250

￦ 7,314,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,250

￦ 8,708,000

※ 부가세 별도